To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

402 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted in Africa. The aim of this study is to estimate the percentage of children and adolescents below or equal to 15 years in Tunisia with acceptably controlled diabetes mellitus type 1.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes

NCT05159856

Diabetes Complications type1diabetes Children, Only +2 more

RECRUITING

Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes

NCT03312478

Type 1 Diabetes

COMPLETED PHASE4

T1DM Clinical Onset and Progression in Paediatric Population

NCT03547440

Type 1 Diabetes Mellitus

COMPLETED

Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents

NCT03014908

Type1diabetes

COMPLETED

Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt

NCT04536285

Type 1 Diabetes Covid19

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Diabetes Mellitus, Type 1

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

insulin

Intervention Type DRUG

Patients will be treated according to routine clinical practice at the discretion of the treating physician.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

insulin

Patients will be treated according to routine clinical practice at the discretion of the treating physician.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol).
* Child or adolescent below or equal to 15 years with diabetes mellitus type 1
* Who has been undergoing treatment for diabetes for at least 6 months